晨间信号Morning Signal
《新科学家》 第3590期 · 2026年4月11日 · 中文解读

广谱抗病毒药物有望治疗感冒和新冠

All-in-one antiviral fights colds and covid · Alice Klein
约 5 分钟News在小程序里点播,20 到 60 分钟做好
这篇讲什么
一种名为MDL-001的药物在实验室研究中能抑制多种常见病毒,包括冠状病毒、呼吸道合胞病毒、诺如病毒以及流感和肝炎病毒,并将在明年进行临床试验。
原文开头
A SINGLE drug has been found to inhibit a range of common viruses in lab studies, including coronaviruses, respiratory syncytial virus (RSV), norovirus, and influenza and hepatitis viruses. It will be tested in a clinical trial next year, raising hopes that the pill could one day be taken at home to relieve unpleasant symptoms. By mining data from old papers and patents, the AI named ERA-923 as a potential candidate that could bind to the Thumb-1 domain and thus block viral replication. “As far as we can tell, this is the first drug that’s ever demonstrated activity across all these viral families,” says Daniel Haders, co-founder of Model Medicines, the California- based company leading its development. …
摘自《新科学家》(New Scientist)第3590期 · 2026年4月11日,Alice Klein。仅引用开头一小段供了解文章,版权归原刊所有,全文请阅读原刊。
晨间信号小程序码
微信扫码,在小程序里听完整版
不用登录先听一篇 · 或在微信搜索小程序 晨间信号
同期其他文章